Hardware, Robotics & IoT VC Funds

Preface Ventures, founded in 2020 and headquartered in New York, focuses on early-stage investments in enterprise infrastructure and software startups. Preface Ventures typically invests between $500k to $2M in pre-seed and seed rounds, with follow-on investments ranging from $1M to $3M. They are known for being the first check in 80% of their investments, and often invest before companies even have a bank account​. Notable investments in their portfolio include companies like Leen, Knock, and Qpoint, reflecting their focus on network management and business productivity software. Preface Ventures has also seen successful exits with companies like Truebill and Remitly. The firm is led by Founder and General Partner Farooq Abbasi, who emphasizes a hands-on approach in the first 100 days of investment, helping startups build financial and board reporting infrastructure. Preface Ventures also assists in constructing seed syndicates, making key customer introductions, and supporting team building efforts​. By leveraging deep industry relationships and a focus on strategic support, Preface Ventures aims to help founders build enduring companies at the frontier of enterprise innovation.

Prelude Ventures, headquartered in San Francisco, is a leading venture capital firm focusing on climate tech investments. Since its inception in 2013, the fund has backed over 150 companies, emphasizing innovative solutions for carbon reduction and sustainability. Notable investments include QuantumScape, a leader in solid-state battery technology; Planet Labs, a satellite imagery provider; and Benson Hill, specializing in plant-based food ingredients. Prelude Ventures concentrates primarily on energy, food, agriculture, and resource optimization sectors, with a geographic focus predominantly in North America. Their investment strategy targets early to growth-stage companies that have the potential to significantly impact climate change. They prefer leading rounds and often provide substantial follow-on funding to support scaling. The fund’s average check size varies, typically ranging from $1M to $20M, depending on the stage and needs of the company. Prelude Ventures is known for being active and engaged investors, offering strategic guidance and leveraging their extensive network to support portfolio companies. Key team members include co-founders Gabriel Kra and Nathaniel Simons, and managing directors Mark Cupta and Matt Eggers. The team is based in San Francisco and is highly experienced in both investment and operational roles within the clean tech and sustainability sectors.

Prequel Ventures is a Berlin, Germany-based venture capital firm founded in 2022 by Mathias Bosse and Markus Boerner, who serve as the fund's two managing partners. The firm focuses exclusively on pre-seed investments in sustainable supply-chain, logistics, and industrial technology startups across Europe. Prequel's mission is to back visionary founding teams building more resilient, efficient, transparent, and sustainable supply chains — and to provide both capital and deep operational support from the earliest stages of formation. The firm announced its First Closing and is actively deploying across Germany, the United Kingdom, and France. Check sizes range from early-stage entries up to EUR 5 million, with a pre-seed sweet spot. Sector coverage spans B2B SaaS, AI, robotics and drones, supply-chain software, fintech, and manufacturing and industrial technology. As of October 2025 the firm has made 26 disclosed investments across an active portfolio of roughly 8 companies, with 3 investments in 2024 and 1 in 2025. Notable portfolio companies include Resourcly (industrial inventory sharing for circular supply chains — most recent investment, Seed VC-II, October 2025), Neutreeno (low-carbon procurement software for suppliers, invested October 2024), Bonx (modern ERP), PHINXT, and NIMMSTA. The broader co-investor network includes co-investors drawn from top European VC and deep-tech communities. Prequel's focus on supply chain is both timely and concentrated: geopolitical disruption, sustainability regulation, and the rising cost of inventory inefficiency have collectively elevated supply-chain software from a back-office concern to a board-level priority for European industrials. Bosse and Boerner bring direct operational insight into where the most acute founder-solvable problems exist across the supply chain, and provide hands-on support to help early-stage teams navigate enterprise sales cycles and corporate pilot programs.

PreSeed Ventures, based in Kongens Lyngby, Denmark, is a prominent early-stage venture capital firm founded in 2000. The firm focuses on investing in startups within the life sciences, information technology, advanced manufacturing, and clean technology sectors, primarily in Denmark and Sweden. PreSeed Ventures has a diverse portfolio featuring companies like Trustpilot, an online review platform that went public in 2021, and Vivino, a popular online wine community platform. Other significant investments include Templafy, a template management platform, and Coinify, a crypto-based payment solution. The firm has also seen successful exits, such as Heyhack, acquired by F5 Networks, and Pento, a payroll automation service. The firm typically invests in seed and early-stage rounds, providing not only capital but also strategic support to help startups scale and achieve significant milestones. PreSeed Ventures is known for its commitment to fostering innovation and supporting ambitious entrepreneurs in building transformative companies.

Presidio Ventures, the corporate venture capital arm of Sumitomo Corporation, has been a significant player in the VC landscape since 1998. Based in Silicon Valley, Boston, and Los Angeles, Presidio Ventures focuses on early to growth-stage investments in enterprise IT, cybersecurity, AI, digital media, mobility, IoT, fintech, and robotics. Notable portfolio companies include Shapeways, Global Thermostat, and Falkonry, showcasing their broad investment scope. Presidio Ventures strategically supports startups with financial backing and business development expertise, leveraging Sumitomo's vast network to help these companies scale globally. Their investment strategy centers on identifying transformative technologies that address pressing global needs, from urbanization solutions to advancements in AI and digital media. The team, led by CEO Doug Kuribayashi, emphasizes collaboration with entrepreneurs to ensure success from early-stage investments to IPO. Their approach includes rigorous due diligence and a focus on scalable solutions with significant market potential. Presidio Ventures prefers detailed pitch decks that demonstrate innovative solutions and clear business models. Their expansive network and industry expertise make them a valuable partner for startups aiming to make a substantial impact in their respective fields.

Presight Capital, founded in 2019 by Christian Angermayer in partnership with Apeiron Investment Group, is a global venture capital firm based in West Hollywood, California. The firm manages over $600 million in assets across two early-stage funds and focuses on investing in biotechnology, consumer, fintech, deep tech, food tech, cryptocurrency, healthcare, and technology sectors. Notable investments by Presight Capital include ATAI Life Sciences, a mental health company using psychedelics; AbCellera, a biotech firm specializing in antibody therapies; and Compass Pathways, which focuses on mental health treatments using psilocybin. Other prominent companies in their portfolio are General Fusion, EnergyVault, and Perfect Day, which produces lab-grown dairy products. Presight Capital aims to support ambitious founders by providing capital, connections, and strategic advice. They invest in various stages, from seed to IPO, and have a diverse portfolio that includes companies like Razor Group, Syfe, and Alto Neuroscience. The firm's approach is characterized by a strong emphasis on transformative technologies and groundbreaking solutions across different industries​.

Presto Ventures (formerly BVC — Bohemia Venture Capital) is a Prague, Czech Republic-based venture capital firm founded in 2016 by Premysl Rubes, a Czech mathematician and entrepreneur, with backing from Czech billionaire and philanthropist Tomas Krsek. Presto invests into fast-growing technology companies across Central and Eastern Europe, primarily at seed and Series A, with selective pre-seed entries. The firm leads rounds and has backed over 50 companies spanning fintech, SaaS, online marketplaces, food, energy, deep tech, and hardware. Presto is backed entirely by private capital — successful entrepreneurs, exited tech founders, and family offices — rather than public or EU grant funding. The firm's portfolio has attracted over EUR 300 million in follow-on capital from Western VCs including Andreessen Horowitz and Point Nine. Notable portfolio names include Cloudtalk, Ready Player Me, Oddin.gg, Woltair, IP Fabric, Sharry, Yieldigo, Inventoro, Finmap, Secfense, Zypl.ai, GaiaNet.AI, and bavovna.ai. Combined AUM from Funds I through III materially exceeds EUR 100 million. In partnership with Czechoslovak Group, Presto launched the EUR 150 million Presto Tech Horizons fund targeting frontier security, defense, aerospace, and dual-use technologies — the first dedicated defense-tech venture fund in the CEE region. Its most recent disclosed investment was a Series A lead in Choice in March 2026. Presto's decade of operating in CEE has produced a pattern-recognition advantage in identifying technical founders from the region who can scale globally. The firm's dual mandate — conventional B2B tech through Funds I-III and defense and dual-use tech through Presto Tech Horizons — positions it uniquely as European governments and NATO members accelerate investment in sovereign technology capabilities. Its willingness to lead rounds from seed through Series A makes it a decisive first institutional partner for CEE founders.

Previz Ventures is a tech and life sciences-focused early-stage venture capital firm founded in 2011 and headquartered in Herzliya, Israel. The firm invests into innovative technology companies addressing critical challenges in medical devices and healthcare information and communications technology, with a clearly defined entry point at post proof-of-concept, initial-to-approaching-commercial stage companies targeting large, underserved markets with scalable solutions. Previz concentrates overwhelmingly on Israeli-based companies to leverage the density of deep-tech talent in the Israeli ecosystem and the unique market access of its management team. The firm is led by founder and Managing Director Eliav Azulay Oz and operates with a small three-person team consistent with its selective, concentrated portfolio strategy. Previz has made approximately 8 disclosed investments and has a strong exit track record relative to its size. ReWalk Robotics (formerly Argo Medical) — a powered exoskeleton enabling paralyzed individuals to walk, stand, sit, and climb stairs — completed a NASDAQ IPO in September 2014 at an approximately $136 million market cap. Orpheus Medical, an enterprise clinical-video imaging platform, was acquired by Intuitive Surgical in February 2020. Clear-Cut Medical (intra-operative compact MRI for margin assessment of cancerous tissue) was among the firm's later disclosed investments. Previz screens investment candidates not only for financial return potential but for the transformative social value they can create in healthcare — improving patient outcomes, quality of life, and access to care. This dual mandate shapes the firm's portfolio construction: each company must meet a high bar on both clinical significance and commercial scalability. The firm provides ongoing strategic guidance across the full investment life cycle, from initial product development through regulatory clearance and downstream financing.

Primary Venture Partners, established in 2015 and headquartered in New York City, is a leading seed-stage venture capital firm focused on transforming startups into market leaders. The firm is co-founded by Brad Svrluga and Ben Sun, who have built a unique approach to venture investing that emphasizes high-conviction, low-volume investments with extensive operational support. Primary Venture Partners specializes in industries such as B2B SaaS, fintech, health tech, dev tools, and supply chain solutions. They are dedicated to New York City-based startups, leveraging their deep local network and resources to drive growth from seed to Series A and beyond. Their notable portfolio companies include Alloy, Alma, and Chief, each demonstrating their commitment to supporting groundbreaking technology and innovative business models. Primary differentiates itself with its "Primary Impact" team, which provides unparalleled support in areas like hiring, sales, and financial strategy. This team, often outnumbering the investors themselves, helps portfolio companies secure customers, build teams, and raise subsequent funding rounds, boasting a Series A success rate twice the industry average.

Prime Impact Fund is a $50 million venture capital fund dedicated to investing in transformative technology companies that aim to have a significant impact on climate change. Launched in 2018, the fund is an initiative of the Prime Coalition, an organization focused on unlocking catalytic capital to address climate challenges. Prime Impact Fund targets early-stage ventures with the potential for gigaton-scale emissions reductions, supporting high-risk, high-reward innovations that traditional capital sources often overlook. The fund's portfolio includes a wide array of companies working on cutting-edge technologies, such as Charm Industrial, which converts waste biomass into bio-oil for underground storage, and Lilac Solutions, which focuses on environmentally-friendly lithium extraction. The fund evaluates investments with rigorous attention to both techno-economic viability and climate impact, ensuring that each investment has the potential to drive substantial environmental benefits. Managed by Azolla Ventures, the Prime Impact Fund is driven by a diverse and experienced team, including Managing Directors Matthew Nordan, Dr. Johanna Wolfson, and Amy Duffuor, all of whom bring extensive backgrounds in technology and impact investing. The fund's unique structure, combining a nonprofit mission with a for-profit investment approach, allows it to maintain a strong focus on its goal of advancing a low-carbon economy.

Prime Movers Lab is a venture capital firm dedicated to investing in breakthrough scientific startups that have the potential to transform major industries and impact billions of lives. Their diverse portfolio includes notable companies such as Boom Supersonic, which is developing supersonic airliners, and Axiom Space, which aims to build the first commercial space station. Other significant investments include Quantum Space, Lyten, and Heliogen, showcasing their focus on innovative technologies in aerospace, energy, and sustainable materials​. Prime Movers Lab primarily invests in early-stage companies, often leading funding rounds with substantial checks that can range significantly based on the needs of the startup. Their investment strategy emphasizes deep scientific and technological advancements that offer solutions to global challenges. They seek out companies with the potential for high growth and significant impact, preferring those that demonstrate strong scientific foundations and transformative potential. The firm is based in Jackson, Wyoming, and operates with a mission-driven approach, looking to partner with visionary founders who are committed to pushing the boundaries of innovation. Key team members include Dakin Sloss, the founder and general partner, who has a robust background in supporting transformative startups. Amy Kruse, a general partner, leads life sciences investments with expertise in neuroscience and synthetic biology. Prime Movers Lab is known for its hands-on approach, providing not just capital but also strategic support, mentorship, and access to a network of industry experts. This approach helps their portfolio companies accelerate their growth and achieve their ambitious goals.

Prime Venture Partners, founded in 2011 and headquartered in Bengaluru, India, is an early-stage venture capital firm focusing on high-potential technology startups. The firm aims to back category-defining businesses with strong founders and technology at the core. Prime Venture Partners has made numerous notable investments across various sectors. Their portfolio includes companies like MyGate, an app-based security and community engagement platform for gated communities; Niyo, a premium travel account for globetrotters; Freo, India’s first credit-led neobank; and Perpule, a self-checkout and omnichannel engagement platform. Other significant investments are KredX, a B2B invoice discounting platform, and Tracxn, a market intelligence platform for private market investing. The firm has supported over 55 companies, with notable exits including Affable, an influencer marketing platform; Happay, a corporate expense management platform; and Ezetap, a point-of-sale payment solutions provider. Their investment strategy involves providing capital and strategic guidance, focusing on creating long-term value and fostering innovation. Prime Venture Partners is led by co-founders Shripati Acharya, Sanjay Swamy, and Balaji Parthasarathy, along with Managing Partner Amit Somani. They emphasize a hands-on approach, working closely with founders to help them navigate the challenges of building scalable businesses​.

Prime Ventures, established in 1999 and headquartered in Amsterdam, is a venture capital firm that focuses on investing in European technology companies. The firm targets industries such as consumer internet, e-commerce, digital media, software, mobile computing, communications, infrastructure services, semiconductor, and clean technology sectors. Prime Ventures has over €875 million in committed capital and has invested in more than 50 companies since its inception. Notable investments by Prime Ventures include Mendix, a low-code software platform acquired by Siemens; Takeaway.com, which has become a leading global food delivery service; and Creative Group, a fintech company specializing in digital top-up services for prepaid credit, which has raised significant funding to expand its international reach. Other prominent companies in their portfolio include CybelAngel, an advanced digital risk management platform, and TerraPay, which provides cross-border payment solutions. Prime Ventures is known for its hands-on approach, working closely with founders to scale their businesses and realize their vision. The firm has a strong track record of successful exits, such as the acquisition of Intrinsic ID by Synopsys and aiMotive by Stellantis, highlighting its ability to support startups from early stages to profitable exits. The team at Prime Ventures includes experienced professionals like Joost Holleman, Margaret Perchik, and Monish Suri, who bring a wealth of knowledge and expertise to their portfolio companies.

Primetime Partners is an early-stage venture capital firm based in New York, focusing on investing in startups that cater to the aging population. Founded in 2020 by Wall Street veteran Alan Patricof and wellness executive Abby Miller Levy, the firm aims to address the needs of older adults, a demographic expected to double to 1.6 billion by 2050. Primetime Partners' investment strategy revolves around seed and early-stage investments, typically ranging from $250,000 to $1 million. The firm focuses on sectors like healthcare, fintech, consumer products, and media, with the goal of improving the quality of life for older adults. Their portfolio includes companies that provide products and services in areas such as aging in place, financial security for retirees, and care management​. The firm also emphasizes supporting older entrepreneurs, recognizing the value of their experience and insights. Patricof and Levy bring a wealth of experience in both investment and operational roles, enhancing their ability to support portfolio companies beyond just financial investment​.

Princeville Capital is a global venture capital firm founded with a focus on investing in growth-stage technology companies. The firm has offices in key global hubs, including San Francisco, Berlin, and Hong Kong. Princeville Capital operates two main funds: Princeville Global, which invests in technology market leaders, and Princeville Climate Tech, which focuses on companies that leverage technology to address climate change challenges. Princeville Capital targets sectors such as enterprise SaaS, AI, fintech, digital health, e-commerce, and blockchain/web3. The firm's investment strategy emphasizes backing companies that are not only leaders in their fields but also have proven business models and are positioned for rapid growth. Princeville’s global reach allows them to apply best practices from various markets and support companies in expanding their operations internationally. The firm’s leadership team includes experienced professionals like Emmanuel DeSousa and Joaquin Rodriguez Torres, who bring a wealth of knowledge in capital markets and strategic growth. They provide strategic counsel and help portfolio companies with follow-on capital raises and IPO preparations, ensuring that they are well-positioned for long-term success.

Prithvi Ventures is a New York City-based climate-tech venture capital firm founded in 2020. The name Prithvi — meaning 'earth' in Sanskrit — signals the firm's mission: invest in early-stage, ambitious startups that fight climate change by driving measurable global reductions in greenhouse gas emissions. The firm's investment philosophy is to back 'boring problems with interesting solutions,' taking a deliberately monopolistic view of climate-solution market structure — preferring companies that can durably own a segment of the climate-tech stack rather than competing in crowded consumer plays. Co-founder Vivek Soni and General Partner Kunal Sethi lead the firm, which places explicit emphasis on diversity: roughly one-third of the portfolio is led by underrepresented founders, a share Fund II is designed to at least double. Fund II targets $50 million in commitments dedicated to seed-stage climate tech; the firm's total book value across 36 startups is approximately $52.3 million per Axios reporting. Prithvi has made 46 disclosed investments across cleantech, energy, food technology, agtech, SaaS, and hardware and robotics. Named portfolio companies include dClimate (decentralized climate data network), De Novo Foodlabs (alternative food technology), and Cyclops (most recent disclosed investment, February 2025). The portfolio spans environmental services, business productivity software, and food products. Prithvi's approach is systematic rather than thematic: the firm evaluates each company against quantified emissions-reduction potential and addressable market size before making an investment decision. This rigor, combined with an active LP and advisory network of climate operators and angels, allows Prithvi to provide portfolio companies with both technical credibility and access to the corporate sustainability buyers and policymakers who are most consequential for climate-tech commercial outcomes.

Pritzker Group, founded by the Pritzker family, is a diversified investment firm with a robust portfolio spanning private capital, venture capital, and asset management. Their investment strategies leverage a permanent capital base, allowing for flexible, long-term investments without the constraints of traditional funding timelines. This approach benefits from the Pritzkers' extensive network, which includes access to advisors, strategic partners, and customers. Notable investments by Pritzker Group Venture Capital include high-profile companies such as Coinbase, SMS Assist, and SpotHero. The group focuses on sectors such as vertical SaaS, marketplaces, and healthtech, supporting companies from seed to growth stages. Their portfolio also includes companies like Cameo and G2 Crowd, showcasing their emphasis on innovative, scalable businesses. The private capital division of Pritzker Group focuses on acquiring and building leading middle-market companies in North America, with investments in industries like manufacturing, logistics, life sciences, and healthcare. Significant investments include firms like TMS International and STV Inc. Pritzker Group's asset management arm allocates capital globally to top-tier investment managers, providing diversified and strategic growth opportunities. Their comprehensive support for portfolio companies includes strategic guidance and leveraging their extensive network to accelerate growth and innovation​.

Privilege Ventures SA is a Swiss, FINMA-authorized early-stage venture capital firm founded in 2016 and headquartered in Lugano, Switzerland, with additional offices in Zurich and Boston. It is the venture capital arm of Privilege Management and is widely recognized as Switzerland's first female-led venture capital firm. The firm's investment thesis is grounded in a data-driven rationale: gender-mixed teams and women-led companies produce better financial outcomes, and Privilege frames this as an economic-return argument rather than a fairness one. The team of approximately ten people, including four Partners and two Venture Partners, spans Switzerland and Italy and brings deep expertise in entrepreneurship, management, finance, and governance. Privilege Ventures invests at seed and early-stage across three thematic pillars: healthtech, agrifood technology, and cleantech, with additional exposure to industrial tech, med-tech, wearables, and broader ICT. Its geographic footprint covers Switzerland and the rest of Europe, with selective Boston-based investments. The firm has approximately 40 portfolio companies. Notable names include Xsensio (wearable skin-chemistry monitoring, most recent disclosed investment March 2026), Adiposs (CHF 4 million Series A, June 2025), AgroSustain, Enantios, SONIX (May 2025), and SMEETZ (March 2025). Beyond capital, Privilege Ventures provides strategic support and mentorship throughout the investment lifecycle, with particular depth in helping portfolio companies navigate Swiss and European regulatory environments and institutional sales. Its status as Switzerland's first female-led VC has generated a differentiated LP base and a co-investor network that values diversity-aligned deal flow, creating a reinforcing pipeline advantage in sourcing and winning competitive seed rounds from underrepresented founding teams across the European life sciences and deep-tech ecosystem.

Procyon Ventures is a Cambridge, Massachusetts-based early-stage deep-tech venture capital firm founded in 2014, now operating under the First Star Ventures brand (firststar.vc) — Procyon Ventures I remains the legacy debut fund. The firm was co-founded by Drew Volpe (background in conversational AI, search, unstructured databases, computational biology, and blockchain) and Millie Liu (background in AI and machine learning analytics, and co-founder of Sequoia China-backed Infervision, an AI medical imaging company). The firm's articulated thesis is 'computing x real-world' — with concentration in techbio, climate, robotics, and industrial infrastructure, and legacy coverage spanning computational biotech, connected sensors, AR/VR, and blockchain. First Star primarily writes pre-seed, seed, and selective Series A checks. The firm is headquartered at 245 Main Street, Cambridge, Massachusetts. As of early 2025 the combined platform has made 48 disclosed investments across ten-plus years, including 4 investments in 2024 and 1 in 2025. Notable portfolio companies include Bedrock Energy (advanced geothermal heating and cooling with proprietary boring technology up to five times faster than conventional methods — Series A, January 2025), Plus One Robotics (pick-and-place warehouse robotics), Scoot Science (ocean and aquaculture data science), and Infinite Analytics. The Procyon/First Star team's technical depth — spanning conversational AI, biotech computation, and machine learning at the co-founder level — allows the firm to engage credibly with founders working on genuinely hard scientific and engineering problems. This hands-on scientific orientation is rare among early-stage VCs and positions the firm as a valued partner for researchers and technical founders who find conventional VC feedback lacking in domain rigor. The firm's Cambridge location provides direct access to MIT and Harvard's deep-tech research ecosystems.

Proeza Ventures is a Monterrey, Mexico-based early-stage venture capital firm founded in 2019 that invests exclusively in the mobility sector — industrial tech, smart components, new vehicles, Mobility-as-a-Service, and digital data services. The firm is recognized as the largest mobility-focused VC fund established in Latin America and maintains a secondary office in Houston, Texas to support US deal flow. Proeza is backed by Grupo Proeza, a Mexican portfolio management company that operates Metalsa — a Tier-1 supplier of structural automotive products and the North American market leader in frames for light trucks. The fund is led by Managing Partners Enrique M. Zambrano and Rodolfo Elias Dieck, CFA. The firm's thesis holds that regulatory pressure, climate commitments, urbanization, and digital transformation are collectively forcing a fundamental rewiring of how people, goods, data, and energy move. Fund I targeted approximately 15 companies at a disclosed size of roughly $50 million, with initial checks averaging approximately $1.5 million. Fund II is being raised at a $70 million target. As of October 2025 the firm has made approximately 22 disclosed investments; notable portfolio names include Solvento ($12.5 million Series A, November 2024), Cargado (freight brokerage software), BUSUP (corporate shuttle platform), Xos Trucks (electric commercial trucks), and Ridepanda (most recent disclosed investment, October 2025). Proeza's industrial heritage through Metalsa gives it a genuine advantage in mobility investing: portfolio companies gain access to Grupo Proeza's Tier-1 supplier relationships, manufacturing facilities, and automotive OEM connections that would take years to build independently. The firm's geographic focus on the Americas — with selective exposure to Western Europe and Israel — positions it at the center of nearshoring-driven supply-chain realignment and the rapid electrification of commercial transportation.

Progression is the TikTok alumni fund. We write first checks in visionary consumer tech founders. Consumer tech is at the beginning of a Super Cycle driven by AI. We are investing in a new wave of founders who are building AI native products that are transforming the lives of everyday consumers.

Project A Ventures, founded in 2012 and based in Berlin, is a leading early-stage venture capital firm. The firm is renowned for its "operational VC" model, which goes beyond providing capital by offering extensive operational support through its team of over 140 functional experts. This team helps portfolio companies excel in areas such as tech, growth, data, and people. Project A focuses on sectors like fintech, digital health, logistics, eCommerce, proptech, B2B enterprise software, and mobility. They invest from pre-seed to Series A stages, with initial investments ranging from $1 million to $10 million, and reserves up to $30 million for future rounds. Their latest fund, which closed at $375 million, brings their total assets under management to $1 billion. Notable portfolio companies include Trade Republic, Kry, sennder, WorldRemit, Spryker, and Voi​.

Prolog Ventures is a U.S.-based venture capital firm that focuses on early-stage investments in health, wellness, and sustainability. With offices in St. Louis and San Francisco, Prolog has a strong track record of backing startups that promote healthier lives and a healthier planet. Notable investments include Plum Organics, a pioneer in organic baby food, and Benson Hill, an agricultural tech innovator. Their portfolio spans consumer health, agtech, and wellness products. Prolog Ventures primarily targets startups in North America, with a particular emphasis on business models that enhance well-being through innovative ingredients, products, and delivery mechanisms. Their partnership with Lonza extends their reach into functional foods, dietary supplements, and personal care. Prolog's strategy revolves around investing in visionary companies that align with their ethos of supporting healthy living. The firm prefers to get involved early, often leading rounds with check sizes ranging from $500K to $5 million. They value long-term partnerships and often leverage their deep network in healthcare and consumer products to help portfolio companies scale. The team is led by co-founders Greg Johnson, Brian Clevinger, and Ilya Nykin, all of whom bring decades of expertise in life sciences and venture capital.

Prologis is a global leader in logistics real estate, offering premier warehousing and distribution solutions. Headquartered in San Francisco and founded in 1983, Prologis operates across the Americas, Europe, and Asia. Their strategic locations near major markets enhance supply chain efficiency for customers. Prologis is committed to sustainability, integrating eco-friendly practices into their operations and building designs to reduce carbon footprints and enhance energy efficiency. They also invest in renewable energy projects and sustainable building certifications. The company provides comprehensive development services, including build-to-suit facilities, property management, and consulting services, ensuring tailored solutions for clients. The Essentials Platform offers end-to-end supply chain solutions, including logistics, transportation, and value-added services. Prologis is known for strategic capital partnerships, providing co-investment opportunities to institutional investors, which enhances their capacity to develop and manage high-quality logistics real estate. Prologis' innovative approach and dedication to customer service and sustainability make it a standout in the logistics real estate sector, combining efficient infrastructure with a strong commitment to environmental responsibility.

Promus Ventures is a venture capital firm specializing in early-stage investments in deep-tech software and hardware companies. Founded in 2012, the firm has a global focus with offices in Chicago, San Francisco, and Luxembourg. Promus Ventures targets innovative sectors such as space technology, artificial intelligence, and advanced manufacturing. The firm has an impressive portfolio that includes notable companies like Rocket Lab, Mapbox, and Whoop. Rocket Lab, a leading space launch provider, and Whoop, a performance optimization wearable, are among their most successful investments, both achieving unicorn status. Promus Ventures also invests in companies like ICEYE, which operates the largest synthetic-aperture radar (SAR) satellite constellation. Promus Ventures' investment strategy emphasizes backing visionary and tenacious founding teams. They focus on transformative technologies with the potential to digitize mature industries and create significant market impact. Their approach involves close collaboration with portfolio companies, providing strategic guidance and leveraging their extensive network to support growth and scalability. The leadership team includes Mike Collett, based in Chicago, Pierre Festal in Luxembourg, and Gareth Keane in Santa Clara, each bringing extensive experience in technology and venture capital. The firm’s commitment to deep-tech and its global perspective make it a significant player in the venture capital landscape.

Propagator Ventures is an Oslo-based venture capital firm founded in 2018, focusing on early-stage investments in deep tech startups. The firm is dedicated to bringing breakthrough science and engineering innovations to market, particularly in areas such as quantum computing, artificial intelligence, advanced materials, and computational biology. Propagator Ventures invests in companies that are developing transformational technologies with the potential to address some of the world's most pressing challenges. Their portfolio includes a range of innovative startups like Genesis Therapeutics, which is at the intersection of AI and biotech for drug discovery, and Universal Quantum, which is working on modular quantum computing hardware. The firm is particularly active in the Seed and Series A stages, with a strong presence in sectors like semiconductors, robotics, and high-tech computing. The team at Propagator Ventures includes experienced partners and advisors who are deeply embedded in the scientific and technological communities, helping to guide startups from early-stage development to scalable enterprises. The firm’s approach is collaborative, often co-investing with other leading venture funds to maximize the impact and growth potential of their portfolio companies. Their investments are globally oriented, with significant activity in the U.S., Europe, and Japan.

Propel Venture Partners is a venture capital firm dedicated to investing in the new financial economy. Founded in 2016, Propel focuses on early-stage investments ranging from pre-seed to Series A, with typical investment amounts between $1.5 million and $12 million. The firm targets startups that enable, accelerate, deliver, and secure financial services across the Americas, including the US, Brazil, and Mexico. Propel's portfolio features a diverse array of innovative companies such as Brave, Coinbase, Groww, and Guideline. These companies are at the forefront of financial technology and digital services, spanning sectors like blockchain, fintech, and digital payments. The Propel team is led by experienced professionals including General Partners Jay Reinemann and David Mort. Jay has over two decades of experience in early-stage investing, with a background at Visa and BBVA. David brings a decade of venture capital experience from his time at SVB and BBVA. Propel offers a collaborative approach to investing, willing to both lead and follow in funding rounds while actively supporting the growth of their portfolio companies.

Propel(x), co-founded by Swati Chaturvedi and Lisheng Wang, is an online investment platform that connects science and technology startups with accredited investors. The platform focuses on deep tech startups in sectors such as energy, green technology, aerospace, life sciences, IT, communications, industrial technologies, and financial services. Notable investments facilitated through Propel(x) include Brelyon, which develops immersive display technology with backing from Lockheed Martin and the E14 Fund, and BlockApps, an enterprise blockchain platform supported by Morgan Creek and Liberty City Ventures. Repurpose, a company working to reduce single-use plastics, is another example, with investors like Chaifetz Group and SWAT Equity Partners. Ligandal, a biotech firm specializing in regenerative medicine and pandemic defense technology, also raised capital on the platform with support from Y Combinator and Techstars. Propel(x) offers Special Purpose Vehicles (SPVs) to pool funds, allowing investors to meet higher investment minimums. This approach democratizes access to early-stage investments in groundbreaking technologies. The platform ensures comprehensive due diligence and curated deal flow, providing investors with well-vetted startups. Propel(x) has been recognized for making early investment opportunities accessible to a broader range of investors.

Propeller Ventures is an early-stage venture capital firm founded in 2022, focusing on ocean-climate solutions. The firm is headquartered in Boston, Massachusetts, and has raised a $100 million fund to invest in companies that leverage ocean-based science and technology to tackle climate change. Propeller aims to support innovations in areas such as carbon removal, ocean-based renewable energy, maritime transport decarbonization, biotechnology, and marine life conservation​. Propeller's leadership team includes notable figures such as Brian Halligan, co-founder and Executive Chairperson of HubSpot, and Dr. Julie Pullen, a climate scientist and oceanographer. The firm has a unique partnership with the Woods Hole Oceanographic Institution (WHOI), providing access to cutting-edge ocean science and technology to enhance their investment strategy. Propeller also offers an Ocean MBA program designed to empower early-stage ocean entrepreneurs with the skills necessary to grow their ventures. This program is part of their broader initiative to accelerate ocean-based solutions and foster a new wave of innovation in the blue economy.

Prospect Venture Partners is a Palo Alto, California-based life-sciences venture capital firm founded in 1997 by Alex Barkas, Ph.D. and David Schnell, M.D., both formerly of Kleiner Perkins Caufield and Byers. Since inception, the firm has raised more than $1 billion of committed capital from foundations, endowments, pension funds, and other institutional limited partners across three flagship funds — Prospect Venture Partners I through III — making it one of the most established dedicated biomedical venture firms on the West Coast. The four Managing Partners are Alex Barkas, David Schnell, Russell Hirsch, M.S., Ph.D., and Jim Tananbaum, M.D., together representing decades of combined life-sciences venture experience. Prospect leads rounds and ultimately invests $10 million to $20 million per company across new-company incubations, first and second venture financings, and later-stage private and public expansion capital. The firm's mandate is commercially attractive biomedical enterprises with outstanding entrepreneurial management teams, proprietary products, and innovative technologies. Across its history, Prospect has recorded approximately 161 investments and 38 portfolio exits. Notable exits include Amira Pharmaceuticals (acquired by Bristol-Myers Squibb for $475 million in 2011) and Gloucester Pharmaceuticals (acquired by Celgene for $640 million in December 2009). The most recent disclosed exit was Nanosys in September 2023. Prospect's founding pedigree — two Kleiner Perkins partners building an independent life-sciences franchise in 1997 — gave the firm early access to the first generation of genomics and biotechnology companies and established LP and syndication relationships that have compounded over nearly three decades. Though the firm did not close a Fund IV and is not making new primary bets, its existing portfolio and governance roles continue to generate activity across its established base of biotech, pharma, and medical-device holdings.

Prospective Technologies VC (PTV) is a New York City-based early-stage venture capital firm founded in 2021 by Alex Kuraksin, Sergey Negodyaev, and Nikita Yuriev. The firm was originally conceived to help Russian and broader Eastern European B2B startups scale internationally via the United States; its portfolio consequently spans US, Canadian, and Eastern-European-origin companies. Sergey Negodyaev and Alexander Kuraksin serve as Managing Partners — Sergey sets fund strategy and vision while Alex owns strategy, partnerships, finance, operations, and deal structuring. The team's cumulative expertise spans engineering, business development, operations, management consulting, strategic planning, and banking. PTV's fund targets up to $100 million in AUM, with disclosed check sizes of $100,000 to $3 million and a broader deployment envelope of up to $5 million when follow-on capital is included. The firm invests primarily at seed and early Series A into US-based B2B and SMB technology startups with global expansion potential, and frequently provides capital plus hands-on go-to-market and organizational support to founders from technical backgrounds scaling into enterprise customers. As of mid-2025 PTV has made approximately 12 disclosed investments. Notable portfolio names include TraceAir (drone-based construction-site monitoring), TestRigor (AI-driven automated regression testing for apps and websites), Nuvolos (seed investment, February 2025), and Magic Lane (most recent disclosed investment, June 2025). PTV's US-CEE bridge positioning fills a structural gap: founders building in Eastern Europe frequently have strong technical foundations but lack the go-to-market infrastructure and US enterprise network needed to cross the Atlantic. PTV's partners provide direct operational support in those specific areas, with a track record of helping portfolio companies navigate US enterprise sales cycles, build partnerships, and raise downstream capital from US-based institutional investors.

Prosus is a global consumer internet group and one of the largest technology investors in the world, with a focus on high-growth sectors like classifieds, food delivery, payments & fintech, and edtech. The company was founded in 2019 as a spin-off from its parent, Naspers, and is headquartered in Amsterdam, Netherlands. Prosus operates in over 100 markets, with significant investments across Europe, India, Brazil, and more. Notable acquisitions include Stack Overflow and iFood, and it holds major stakes in companies like Swiggy and Bykea. Its portfolio reflects its commitment to backing innovative technologies that improve everyday life for over 2 billion people globally. The company’s investment approach is centered around identifying new waves of growth, especially through early-stage investments led by Prosus Ventures. Prosus is publicly traded on the Euronext Amsterdam, with secondary listings in Johannesburg, and it continues to be majority-owned by Naspers.

Proxima Ventures is a Shanghai, China-headquartered healthcare-specialist venture capital firm founded in 2015. The firm's mission is to improve the health and lives of people worldwide by investing in emerging global healthcare technologies — with thematic concentration across biotechnology, novel therapeutics, medical devices, diagnostics, clinically significant digital healthcare solutions, advanced data analytics platforms, and innovative business models emerging from China's healthcare system reform. Proxima manages multiple funds denominated in both Chinese RMB and US dollars and is stage-agnostic within healthcare — deploying capital across angel, early, and growth-stage rounds with follow-on support through downstream financing. The firm is led by Founding Partner and Managing Partner George Li and Partner Haolin Sung. As of late 2025, Proxima Ventures has made approximately 105 disclosed investments, with consistent recent activity across surgical devices, drug discovery, and digital health. Notable recent deals include Shengxin Medical (surgical devices, most recent disclosed investment, November 2025), BridGene Biosciences (Series B-II, October 2025), Rapafusyn Pharmaceuticals (participated in a $28 million Series A in June 2024 — non-degrading molecular glue drug discovery), and Bioelectronica Corporation (co-invested with Co-win Ventures to accelerate pharmaceutical discovery and development). Proxima's team brings deep operating and investing experience in the life sciences industry alongside an extensive clinical and industrial network inside China. This local knowledge is a meaningful asset: China's healthcare system reform, aging population, and accelerating biotech research ecosystem create deal-flow dynamics and regulatory pathways that require genuine on-the-ground expertise to navigate. The firm's RMB-and-USD dual-currency structure allows it to invest efficiently across both domestic Chinese companies and internationally-oriented biotechs with China market ambitions.

PT1 Ventures, also known as PropTech1 Ventures, is a leading early-stage venture capital firm based in Berlin and London, with a focus on transforming real assets through innovative technologies in the PropTech, ConstructionTech, and GreenTech sectors. The firm supports startups that are tackling critical challenges like energy efficiency, urbanization, and climate change, particularly within the real estate and construction industries. Their investment strategy is centered on creating a "double return" — delivering financial gains for investors while addressing pressing societal needs, such as reducing the carbon footprint of the real estate industry. PT1 Ventures seeks out startups that can modernize existing buildings, enhance energy efficiency, and integrate digital solutions into infrastructure. They are particularly focused on technologies that can drive net-zero modernization, such as carbon capture, next-gen risk assessment platforms, and decarbonizing construction processes. The firm’s portfolio includes a variety of companies that are pioneering sustainable solutions, from scalable renovation technologies to AI-driven property management tools. With a broad network of industry veterans and investors, PT1 is committed to fostering innovation across Europe, supporting entrepreneurs who are reshaping the future of urban living and sustainability. Their approach combines deep industry expertise with a strong focus on Environmental, Social, and Governance (ESG) principles, making them a key player in sustainable venture capital​.

Puget Sound Venture Club (PSVC) is Seattle's oldest angel investor group, founded in 1985 by Gary Ritner, who ran the club for 38 years and remains one of the most influential figures in Pacific Northwest angel investing. PSVC was founded with a straightforward mission: create a small, focused community of accredited investors who represent themselves or their organizations while providing access to the experience and insight of other members. The club's members invest in North American companies with an emphasis on the Pacific Northwest — Washington, Oregon, Idaho, and British Columbia — at seed, early-stage, and first-round stages across most industries, from consumer and food businesses through high-tech and TMT. Across 38 years of operation, PSVC members past and present collectively invested approximately $220 million into more than 1,350 companies, many of which went on to significant outcomes. Notable alumni and companies that have presented to the club include Starbucks, DocuSign, Coinstar (later Outerwall), Clarisonic, Insitu, Theo Chocolate, Julep, and Otonexus. In September 2023, PSVC merged its membership into the Alliance of Angels (AoA) — the largest angel group in the Pacific Northwest, with approximately 160 investors backing more than 20 tech startups per year — with PSVC's roughly 30 members becoming AoA members. Gary Ritner retained ownership of the PSVC brand and joined AoA's Board of Directors. PSVC's nearly four-decade track record represents one of the most durable angel investor networks in the US Pacific Northwest. Its merger with AoA consolidates the region's angel capital into a single platform with greater deal volume, deeper geographic coverage, and a stronger institutional voice for startup-friendly policy in the Washington State ecosystem. The PSVC community and its historical investment culture continue under the combined AoA umbrella.

Puhua Capital, established in 2004 and based in Hangzhou, China, is a prominent venture capital firm with a focus on early and mid-stage investments in cutting-edge technology sectors. The firm is particularly active in industries such as healthcare, semiconductors, energy, and artificial intelligence. Puhua Capital's investment strategy revolves around identifying high-potential startups in sectors like biotechnology, clean energy, and advanced manufacturing, often engaging in rounds ranging from $15M to $50M. Notably, the firm has been involved in significant deals such as investments in Pudu Robotics, a leader in autonomous delivery robots, and Pony.ai, an autonomous driving technology company. Puhua Capital also emphasizes innovation within health and deep tech, backing companies like Creavo Medical Technologies and Laser Link, which specialize in medical devices and optical communication technology, respectively. Led by CEO Shen Qinhua, the team at Puhua Capital leverages their extensive industry knowledge to help scale their portfolio companies both within China and internationally. The firm has a strong track record of successful exits, including IPOs, and maintains a forward-looking approach, investing in technologies poised to transform industries on a global scale​.

Pulsar Venture Capital is a venture capital and startup acceleration platform founded in 2009 and operating from dual hubs in Kazan, Russia and Hermosa Beach, California. The firm maintains an active network of experts across Europe, the United States, Asia, Latin America, and MENA, and specializes in accelerating the growth of high-tech businesses while helping develop venture infrastructure in emerging economies. Pulsar's approach is structured around three pillars: Smart Investment (direct capital into early-stage companies), Growth Consulting (hands-on scaling support), and Applied Networking (introductions to customers, partners, and downstream investors). Key leadership includes Founder and CEO Pavel Korolev alongside Partners Alexander Savchenkov and Leonard Grayver. The firm's preferred sector focus spans fintech, agtech, IoT, marketplaces, mobility technology, travel technology, sports technology, and media and entertainment software. Typical check sizes range from $100,000 to $500,000 at pre-seed through Series A stages. Pulsar reports approximately 50 active portfolio companies and roughly 72 disclosed investments in total. Notable portfolio companies include ConvertBomb (media and information services, most recent disclosed investment, January 2024), Epit, and YouTool. The firm also runs a dedicated acceleration program with a stated goal of activating 1,000 entrepreneurs and 100 investors. Pulsar's Kazan-California dual-hub structure positions it as a connector between Russian and Eastern European technical talent and the US-led global venture market. The firm's hands-on Growth Consulting offering distinguishes it from purely capital-focused early-stage funds: portfolio companies receive direct strategic, commercial, and network support from Pulsar's team and extended expert network, which spans multiple continents and technology verticals. This operating model reflects Pulsar's broader ambition of strengthening the venture ecosystem in markets that remain underserved by conventional institutional capital.

Pureos Bioventures is a venture capital firm focusing on investing in innovative biopharmaceutical companies. Pureos Bioventures targets early-stage to growth-stage companies developing novel therapeutic approaches and technologies in the life sciences sector. The firm is particularly interested in startups that aim to address unmet medical needs and provide transformative treatments for patients. Pureos Bioventures is known for its strategic investments and active involvement in the development of its portfolio companies. The firm leverages its extensive network and deep industry expertise to support the growth and success of the startups it invests in. The investment strategy of Pureos Bioventures typically involves significant initial investments, with the potential for follow-on funding as companies progress. This approach allows the firm to nurture and support its portfolio companies through various stages of development, from early research to clinical trials and commercialization. The team at Pureos Bioventures comprises experienced professionals with backgrounds in biotechnology, pharmaceuticals, and venture capital. Their combined expertise enables them to identify promising investment opportunities and provide valuable guidance and support to their portfolio companies. For startups looking to engage with Pureos Bioventures, it is essential to demonstrate innovative and impactful therapeutic solutions with strong potential for clinical and commercial success. Emphasizing a clear path to address unmet medical needs and the potential for significant patient impact will be key in attracting investment from Pureos Bioventures.

Pymwymic, founded in 1994, is a Netherlands-based impact investment cooperative that channels capital into businesses driving positive environmental and social change. Known for its pioneering role in European impact investing, Pymwymic's mission is to blend financial returns with measurable impact, focusing primarily on sectors such as sustainable agriculture, ecosystem restoration, and food systems. Their investments are managed through SDG-aligned sub-funds like the Healthy Food Systems Impact Fund, which targets startups transforming the global food industry through sustainable technologies. Over the years, Pymwymic has invested more than €60 million into innovative companies, helping them scale while maintaining their social missions. Recent investments include Aurea Imaging, which enhances environmental monitoring using AI, and Weenat, which focuses on data-driven water management​. With over 150 co-owners, Pymwymic operates as a cooperative, bringing together families, entrepreneurs, and institutional investors to co-develop impactful ventures. Their approach emphasizes impact governance, requiring companies to meet specific KPIs related to social and environmental outcomes. This community-driven structure allows Pymwymic to foster deep relationships with its portfolio companies, ensuring that the businesses stay committed to their missions as they grow and that profit never overshadows the planet​.

Q Venture Partners is a venture capital firm established in 2016, headquartered in Hong Kong. The firm specializes in early-stage investments, particularly focusing on industries like consumer electronics, Internet of Things (IoT), artificial intelligence, and healthcare technologies. Q Venture Partners has a global outlook, investing primarily in North American and Asian markets, with a particular emphasis on scalable technologies that have the potential to transform industries. Led by co-founders Henry Tan and Larry Tsai, the firm adopts a hands-on approach, providing strategic guidance and support to its portfolio companies. The firm's investment strategy is focused on sectors where technology can create significant value, driving both innovation and market disruption. Notable investments include companies like StrongArm Tech, AREVO, and Preteckt, which are leaders in their respective fields of wearable technology, advanced manufacturing, and predictive maintenance software. Q Venture Partners is actively seeking new investments and typically participates in Series A and B funding rounds, often collaborating with other leading venture capital firms. The firm has a track record of successful exits, including the merger of AREVO in 2024, reflecting its ability to identify and nurture high-potential startups into market leaders.

QB1 Ventures is a New York-based venture capital firm founded in 2015 as the venture arm of Talpion Fund Management, the multi-asset family office led by Alex Swieca. The firm invests in US- and Israel-based technology companies across enterprise software, fintech, sports technology, consumer technology, and healthtech, seeking startups with scalable core technology that solves a genuine problem in a simplified way. Alex Swieca serves as Founder and Managing Partner, with Kevin Swieca as Venture Partner. QB1 targets Seed and Series A rounds with typical check sizes of $100,000 to $1 million and a sweet spot around $250,000, running a deliberately concentrated portfolio of roughly 10 companies rather than a high-volume fund. Named portfolio companies include WSC Sports (AI-powered sports highlight generation), Yellowdig (community learning platforms), Fan AI (sports fan data analytics), GameCo (skill-based gaming), mPrest (power-grid software), Percepto (industrial autonomous drones), ElMindA (brain analytics), Privasea (fully homomorphic encryption for privacy-preserving AI), and Replay Technologies, which was acquired by Intel. The most recent publicly documented exit was RecoverX, acquired by Hyperice in January 2021. The concentration of the portfolio is a deliberate strategic choice: QB1 prioritizes active engagement with each company over breadth of coverage, working closely with founders on strategy, network access, and follow-on fundraising. The firm's dual US-Israel mandate reflects the family office's existing ties to both markets and its view that Israeli deep technology and US market distribution create a natural and complementary investment pairing.

Qbic, established in 2012 and headquartered in St-Denijs-Westrem, Belgium, is a venture capital fund focused on early-stage investments, particularly in spin-offs from universities, research institutions, and hospitals. The fund supports startups in sectors such as deeptech, biotech, medtech, and software. Qbic has made significant contributions to transforming technological breakthroughs into sustainable businesses. Notable investments by Qbic include Theratrame, which focuses on cancer therapies, Animab, which develops alternatives to antibiotics for animals, and VoxelSensors, which specializes in 3D perception sensors for extended reality applications. Additionally, their portfolio includes companies like AmphiStar in the biotechnology field and Weave.ly in software development. Qbic manages around €200 million across its various funds, with Qbic III recently raising €88.5 million to continue supporting innovative spin-offs. The fund's strategic partners include major Belgian universities and research institutions, providing a strong pipeline of high-potential startups. The team at Qbic, led by Managing Partner Sofie Baeten, is dedicated to fostering technological innovation and supporting the growth of their portfolio companies.

QDNL Participations is a €15 million venture fund based in the Netherlands, dedicated to supporting early-stage quantum technology startups. Backed by the Quantum Delta NL initiative, the fund bridges the gap between academic research and venture capital, focusing on companies working in quantum computing, sensing, communication, and enabling technologies. Their mission is to help researchers transform their cutting-edge innovations into investable businesses. The fund typically invests up to €1.5 million per startup and offers additional pre-seed support of €50,000 to promising teams even before they have formally launched a company. Through its strategic support, QDNL Participations aims to build a sustainable quantum ecosystem in the Netherlands by 2028, providing not only financial backing but also commercial and business development expertise. Their portfolio includes companies like QphoX and Qblox, both leaders in the quantum field. With leadership from prominent figures like Managing Director Ton van 't Noordende and venture partner Chad Rigetti, the fund also offers a unique on-call support program called Infinity, designed to provide startups with access to over 800 deep-tech investors worldwide. This positions QDNL Participations as a key player in scaling quantum startups within Europe​.

Qiming Venture Partners, founded in 2006, is a leading venture capital firm with a strong focus on investments in the technology, consumer, and healthcare sectors. The firm operates with a significant presence in China and the United States, managing over $9.5 billion in capital across 18 funds. Qiming has an impressive portfolio of successful investments, including prominent companies such as Xiaomi, Bilibili, Meituan, and Mindray. These companies highlight Qiming's ability to identify and support high-potential startups that grow into industry leaders. The firm typically invests in early and growth-stage companies, emphasizing sectors like internet and consumer products, healthcare, and technology​​. The investment strategy at Qiming is comprehensive, often providing extensive support to portfolio companies through strategic guidance and leveraging a vast network. Key team members, like Bonnie Wang, focus on internet and consumer investments and have been recognized for their contributions to the venture capital industry​​. With a commitment to fostering innovation and growth, Qiming Venture Partners continues to play a crucial role in the global venture capital landscape, especially within the dynamic markets of China and the U.S.

Qiming Venture Partners USA, launched in 2017, focuses on early-stage investments in healthcare, particularly therapeutics and healthcare technologies, across the U.S. and Europe. Backed by its China-based parent firm Qiming Venture Partners, the U.S. arm leverages both financial and human capital to support transformative innovations in healthcare, including drug development and digital health solutions. With over $550 million raised across three funds, Qiming USA has already invested in more than 30 companies and achieved notable exits through M&A and IPOs. Their strategy is centered on partnering with visionary healthcare entrepreneurs, offering not just capital but also deep technical expertise and a global network, including synergies with the broader Qiming platform in China. Key team members include managing partners like Mark McDade and the recent addition of Isaac Ciechanover, whose extensive background in biotech strengthens Qiming’s healthcare focus. Their third fund, closed at $260 million in 2022, continues to invest in innovative therapeutics and health tech ventures that have the potential to make a significant impact on patient outcomes​.

Quadia, founded in 2010 and based in Geneva, is a leading impact investment firm focused on financing solutions for a regenerative economy. They invest across sectors like clean energy, sustainable food systems, and circular production, with notable investments in companies like Fairphone, Infarm, and Ynsect. Quadia has allocated over €200 million to support transformative ventures primarily across Europe, with a strong focus on France and Switzerland. Their strategy revolves around Series A and growth-stage investments, providing equity and debt to businesses that align with their principles of social and environmental impact. Quadia looks for scalable companies that promote sustainable consumption and regenerative practices, focusing on long-term value creation. They often co-invest with partners like Bpifrance and Danone Manifesto Ventures, building a robust network to amplify the impact of their investments. The firm is led by a small but experienced team, including Guillaume Taylor, with operations extending to a secondary office in Paris. Their mission emphasizes generating attractive returns while advancing the ecological transition, making them a pioneer in Europe’s impact investing landscape​.

Quake Capital, founded in 2016, is a venture capital firm and accelerator headquartered in Seattle, Washington, with a strong presence in New York and Los Angeles. The firm focuses on seed-stage investments, offering substantial support to new and early-stage ventures across a wide range of industries. Through their accelerator program, Quake Capital provides startups with resources, mentorship, and funding to help them grow and succeed. The firm has made over 300 investments in various sectors, including digital health, fintech, AR/VR, gaming, and e-commerce. Notable portfolio companies include NOCD, which offers online therapy for OCD; Blok Party, a platform combining physical, digital, and social play; Vyrill, a user-generated video content discovery and marketing platform; and Grain, which helps individuals build credit through savings. Quake Capital's investment strategy is industry-agnostic, emphasizing innovation and potential for growth. They typically invest $100,000 to $150,000 in each startup that completes their accelerator program. The firm’s founders, Glennon Argenbright, Chad Burgess, Adam Cragg, and Brandon Maier, bring extensive experience in venture capital and entrepreneurship, providing valuable insights and support to their portfolio companies.

Qualcomm Ventures, founded in 2000, is the corporate venture capital arm of Qualcomm Incorporated, headquartered in San Diego, California. The firm focuses on investing in early to growth-stage companies in sectors such as artificial intelligence (AI), automotive, mobile, enterprise and cloud, and smart systems. It supports startups with strategic guidance, leveraging Qualcomm’s extensive technological expertise and global network. Notable investments from Qualcomm Ventures include companies like Cloudflare, Xiaomi, Zoom, and SentinelOne. These companies have achieved significant milestones, including successful IPOs and high-profile acquisitions. For instance, SentinelOne went public in June 2021, and Zoom became a key player in cloud video conferencing and communication services. Qualcomm Ventures manages over $2 billion in assets and has a portfolio of more than 360 companies, with 22 unicorns and 19 companies that have gone public. The firm is also active in fostering innovation through specific funds like the Qualcomm Ventures AI Fund and the 5G Ecosystem Fund, which target emerging technologies in AI, machine learning, and 5G solutions. The investment team is composed of experienced professionals located in various global regions, including the US, China, and Israel, ensuring a broad and strategic reach to identify and support high-potential startups worldwide​.

Quam Venture Capital (Quam VC LLP) is a London-based, FCA-regulated venture capital investment advisor founded in 2012. Rather than managing a single pooled fund, the firm serves as investment advisor to a consortium of general partners overseeing three parallel Europe-domiciled venture funds alongside a portfolio of bespoke special purpose vehicles, allowing flexible co-investment across themes and deal sizes. The five-person team draws on backgrounds across investment banking, finance, law, marketing, management consulting, and technology. Investment sizes range from approximately 500,000 euros for innovative early-stage concepts to around 3 million euros for teams with early revenue traction, scaling to roughly 10 million euros for follow-on support as portfolio companies mature. The firm's thematic mandate is broad: artificial intelligence, space ventures, clean technology and renewable energy, biotechnology, blockchain and distributed ledger technologies, cybersecurity, quantum computing, stem cell and nanotechnology, virtual reality, transportation, and infrastructure. Geographic coverage spans Europe, North America, and Latin America, giving Quam the flexibility to engage with global-ambition founders regardless of domicile. The team includes Josh, an FCA-accredited investment advisor and strategic lead; Vic, a partner with 30-plus years in real estate and 25 years spanning brand marketing, property management, and venture capital; Diogo, who sources and evaluates technology-based startups across biotech, ICT, energy, and tourism; and Andy, who serves on the Investment Committee. The SPV-led structure and preference for discreet deployments rather than publicized fund announcements reflects the firm's focus on bespoke deal-by-deal engagements with strategic investors.

Quantonation is a pioneering venture capital fund focused on early-stage investments in quantum technologies and deep physics. Founded in 2018, the Paris-based fund is dedicated to supporting startups working in quantum computing, quantum communications, quantum sensing, and related fields, aiming to accelerate the commercial adoption of groundbreaking scientific innovations. With over €91 million raised in its first fund, Quantonation has backed more than 30 companies, including notable names like Pasqal, ORCA Computing, and Qubit Pharmaceuticals. The fund's strategy targets startups at the pre-seed and seed stages, emphasizing those with the potential to transition quantum innovations into practical, industry-ready applications. These companies address critical areas such as molecular design, high-performance computing, and cybersecurity, with broader impacts expected in fields like healthcare, energy, and climate change mitigation. Quantonation leverages its deep scientific expertise and global network of research institutions, including partnerships with MIT, Ecole Polytechnique, and Oxford University. Quantonation has recently launched its second fund, Quantonation II, with a target of €200 million, signaling its commitment to expanding its support for quantum startups worldwide. Led by a team of experienced scientists and investors like Christophe Jurczak and Olivier Tonneau, the firm is actively shaping the future of the quantum tech ecosystem.